» Articles » PMID: 31752674

Effects of High Glucose Conditions on the Expansion and Differentiation Capabilities of Mesenchymal Stromal Cells Derived from Rat Endosteal Niche

Overview
Publisher Biomed Central
Specialty Cell Biology
Date 2019 Nov 23
PMID 31752674
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mesenchymal stromal cells in the endosteal niche lining compact bone (CB-MSCs) represent a heterogeneous population, all of which contribute to bone repair and remodelling. Hyperglycaemia associated with type 2 diabetes mellitus (T2DM) can delay and impair the bone healing process. Therefore, this study investigated the influences of high (25 mM) glucose conditions on CB-MSC populations isolated from male Wistar rats, versus normal (5.5 mM) glucose conditions; in terms of proliferation (population doublings, PDs), senescence characteristics, stem cell marker expression, colony forming efficiencies (CFEs); and osteogenic/adipogenic differentiation, following extended culture in vitro.

Results: CB-MSCs under both normoglycaemic and hyperglycaemic conditions demonstrated similar morphologies and rapid exponential growth to >300PDs, although high glucose conditions promoted more rapid and persistent proliferation beyond ~50PDs, with few indications of senescence. Limited senescence was confirmed by minimal SA-β-galactosidase staining, low senescence marker (p53, p21, p16) expression and positive telomere maintenance marker (rTERT, TR) expression. However, telomere lengths varied throughout culture expansion, with hyperglycaemia significantly reducing telomere lengths at PD50 and PD200. Furthermore, CB-MSCs expanded in normal and high glucose conditions remained non-transformed, exhibiting similar MSC (CD73/CD90/CD105), multipotency (CD146) and embryonic (Slug, Snail) markers throughout extended culture, but negligible hematopoietic (CD34/CD45) or pluripotency (Nanog, Oct4) markers. Hyperglycaemia significantly increased CFEs at PD50 and PD100, which decreased at PD200. CB-MSC osteogenic differentiation was also inhibited by hyperglycaemia at PD15, PD100 and PD200, but not at PD50. Hyperglycaemia inhibited CB-MSC adipogenic differentiation to a lesser extent at PD15 and PD50, with reduced adipogenesis overall at PD100 and PD200.

Conclusion: This study demonstrates the limited negative impact of hyperglycaemia on the proliferative and stem cell characteristics of heterogeneous CB-MSC populations, although minor sub-population(s) appear more susceptible to these conditions leading to impaired osteogenic/adipogenic differentiation capabilities. Such findings potentially highlight the impact of hyperglycaemia on CB-MSC bone repair capabilities in situ.

Citing Articles

Biomimetic integration of functionally controlled modular tissue building blocks for engineering 3D vascularized adipose tissue.

Lee S, Lee J, Kwon H, Shin H Bioact Mater. 2025; 48:171-188.

PMID: 40046010 PMC: 11880769. DOI: 10.1016/j.bioactmat.2025.02.024.


Role of oxidative stress in impaired type II diabetic bone repair: scope for antioxidant therapy intervention?.

Li P, Alenazi K, Dally J, Woods E, Waddington R, Moseley R Front Dent Med. 2025; 5:1464009.

PMID: 39917650 PMC: 11797775. DOI: 10.3389/fdmed.2024.1464009.


Hyperglycemia exerts disruptive effects on the secretion of TGF-β and its matrix ligands, decorin and biglycan, by mesenchymal sub-populations and macrophages during bone repair.

Yusop N, Moseley R, Waddington R Front Dent Med. 2025; 4:1200122.

PMID: 39916897 PMC: 11797960. DOI: 10.3389/fdmed.2023.1200122.


Short- and long-term exposure to high glucose induces unique transcriptional changes in osteoblasts in vitro.

Jalava N, Arponen M, Widjaja N, Heino T, Ivaska K Biol Open. 2024; 13(5).

PMID: 38742438 PMC: 11128269. DOI: 10.1242/bio.060239.


High glucose microenvironment and human mesenchymal stem cell behavior.

Mateen M, Alaagib N, Haider K World J Stem Cells. 2024; 16(3):237-244.

PMID: 38577235 PMC: 10989287. DOI: 10.4252/wjsc.v16.i3.237.


References
1.
Izadpanah R, Kaushal D, Kriedt C, Tsien F, Patel B, Dufour J . Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res. 2008; 68(11):4229-38. PMC: 2713721. DOI: 10.1158/0008-5472.CAN-07-5272. View

2.
Levesque J, Winkler I . Hierarchy of immature hematopoietic cells related to blood flow and niche. Curr Opin Hematol. 2011; 18(4):220-5. DOI: 10.1097/MOH.0b013e3283475fe7. View

3.
Colombo J, Balani D, Sloan A, Crean S, Okazaki J, Waddington R . Delayed osteoblast differentiation and altered inflammatory response around implants placed in incisor sockets of type 2 diabetic rats. Clin Oral Implants Res. 2010; 22(6):578-86. DOI: 10.1111/j.1600-0501.2010.01992.x. View

4.
Merlotti D, Gennari L, Dotta F, Lauro D, Nuti R . Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis. 2010; 20(9):683-90. DOI: 10.1016/j.numecd.2010.07.008. View

5.
Jones P, Watt F . Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell. 1993; 73(4):713-24. DOI: 10.1016/0092-8674(93)90251-k. View